Natural ingredient supplier OmniActive has released the results of a new clinical trial that substantiates the effects of its enXtra ingredient as a caffeine-alternative in the growing energy supplement market.
OmniActive Health Technologies, Ltd. and Kemin Industries, Inc. have settled their legal disputes and will cross license ‘use patents’ on lutein, zeaxanthin and their isomers.